129 related articles for article (PubMed ID: 1472745)
21. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
[TBL] [Abstract][Full Text] [Related]
22. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C.
Osicka TM; Yu Y; Panagiotopoulos S; Clavant SP; Kiriazis Z; Pike RN; Pratt LM; Russo LM; Kemp BE; Comper WD; Jerums G
Diabetes; 2000 Jan; 49(1):87-93. PubMed ID: 10615954
[TBL] [Abstract][Full Text] [Related]
23. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
Pugliese G; Tilton RG; Speedy A; Chang K; Province MA; Kilo C; Williamson JR
Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
[TBL] [Abstract][Full Text] [Related]
24. Effects of combined insulin and sorbinil treatment on diabetes-induced vascular dysfunction in rats.
Pugliese G; Tilton RG; Speedy A; Oates PJ; Williamson JR
Metabolism; 1994 Apr; 43(4):492-500. PubMed ID: 8159110
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical distribution of endogenous albumin and immunoglobulins in the glomerular wall of the sucrose-fed "Cohen" diabetic rat.
Livni N; Bendayan M; Gingras D; Rosenmann E; Cohen AM
Diabetes Res; 1990 Jun; 14(2):55-63. PubMed ID: 2134214
[TBL] [Abstract][Full Text] [Related]
26. The effects of dietary cholesterol on experimental diabetic nephropathy.
Cooper ME; Vranes D; Vranes DA; Allen TJ; Panagiotopoulos S; Komers R; Jerums G
Diabetes Res; 1993; 22(4):159-69. PubMed ID: 8070237
[TBL] [Abstract][Full Text] [Related]
27. Loss of sulfated carbohydrate from the glomerular podocyte as a cause of albuminuria in experimental diabetic rats: ultrastructural histochemical study.
Ina K; Kitamura H; Nakamura M; Ono J; Takaki R
J Diabet Complications; 1991; 5(2-3):173-5. PubMed ID: 1770036
[TBL] [Abstract][Full Text] [Related]
28. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME
Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758
[TBL] [Abstract][Full Text] [Related]
29. Tissue differences in vascular permeability changes induced by histamine.
Kilzer P; Chang K; Marvel J; Kilo C; Williamson JR
Microvasc Res; 1985 Nov; 30(3):270-85. PubMed ID: 4088092
[TBL] [Abstract][Full Text] [Related]
30. Interactions between the sorbitol pathway, non-enzymatic glycation, and diabetic vascular dysfunction.
Ido Y; Kilo C; Williamson JR
Nephrol Dial Transplant; 1996; 11 Suppl 5():72-5. PubMed ID: 9044312
[TBL] [Abstract][Full Text] [Related]
31. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats.
Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A
Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170
[TBL] [Abstract][Full Text] [Related]
32. Vascular albumin permeability and hypertrophy in a rat model combining streptozotocin-induced diabetes and genetic hypertension.
Hulthén UL; Rumble J; Cooper ME; Johnston CI
J Hypertens; 1995 May; 13(5):529-33. PubMed ID: 7561010
[TBL] [Abstract][Full Text] [Related]
33. Integrated cardiovascular function in the conscious streptozotocin-diabetic deoxycorticosterone-acetate-hypertensive rats.
Schenk J; Hebden RA; Dai S; McNeill JH
Pharmacology; 1994 Apr; 48(4):211-5. PubMed ID: 8177907
[TBL] [Abstract][Full Text] [Related]
34. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
Mauer SM; Steffes MW; Azar S; Brown DM
Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
[TBL] [Abstract][Full Text] [Related]
35. Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.
Yamashita H; Nagai Y; Takamura T; Nohara E; Kobayashi K
Metabolism; 2002 Apr; 51(4):403-8. PubMed ID: 11912544
[TBL] [Abstract][Full Text] [Related]
36. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
[TBL] [Abstract][Full Text] [Related]
37. Renal-protective effect of nondepressor dose of cicletanine in diabetic rats with hypertension.
Kohzuki M; Wu XM; Kamimoto M; Yoshida K; Nagasaka M; Kanazawa M; Yasujima M; Saito T; Sato T
Am J Hypertens; 2000 Mar; 13(3):298-306. PubMed ID: 10777035
[TBL] [Abstract][Full Text] [Related]
38. Albumin permeation of new vessels is increased in diabetic rats.
Kilzer P; Chang K; Marvel J; Rowold E; Jaudes P; Ullensvang S; Kilo C; Williamson JR
Diabetes; 1985 Apr; 34(4):333-6. PubMed ID: 2579004
[TBL] [Abstract][Full Text] [Related]
39. Role of fibrillin-1 in hypertensive and diabetic glomerular disease.
Hartner A; Schaefer L; Porst M; Cordasic N; Gabriel A; Klanke B; Reinhardt DP; Hilgers KF
Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1329-36. PubMed ID: 16380460
[TBL] [Abstract][Full Text] [Related]
40. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
